Will MediWound Ltd NASDAQ:MDWD meet your expectations?
MediWound Ltd headquartered in Israel is reporting their earnings on 03/25/2019 after the bell. Street forecast for the quarter ending Dec 2018 is $-0.15.
According to stock market daily analyst this is Lower then same time previous year. MediWound Ltd, reported EPS for the same quarter last year was $-0.08.
About MediWound Ltd NASDAQ:MDWD
MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products to address unmet needs. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns in the European Union, Israel, and Argentina. The company also develops EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
|% Change from 52 Week Low|
|% Change from 52 Week High|